The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Regulatory News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.544
Bid: 1.532
Ask: 1.544
Change: -0.106 (-6.42%)
Spread: 0.012 (0.783%)
Open: 1.622
High: 1.658
Low: 1.544
Prev. Close: 1.65
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

5 May 2020 11:06

RNS Number : 9711L
Hemogenyx Pharmaceuticals PLC
05 May 2020
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMUPUAUAUPUGUA
Date   Source Headline
13th Nov 20179:00 amRNSPrice Monitoring Extension
13th Nov 20177:00 amRNSStatement re Press Comment
30th Oct 20177:00 amRNSLakePharma appointed for lead product development
11th Oct 20177:00 amRNSDirector/PDMR Shareholding
10th Oct 20177:00 amRNSDirector/PDMR Shareholding
5th Oct 20178:01 amRNSCornell University update
5th Oct 20178:00 amRNSAdmission & First Day of Dealings
4th Oct 201711:16 amRNSResult of General Meeting
26th Sep 20177:00 amRNSInvestor presentations
25th Sep 20177:00 amRNSHalf-year Report
11th Sep 20177:00 amRNSProposed acquisition and Placing & Subscription
13th Apr 20173:30 pmRNSFinal Results
30th Sep 20162:00 pmRNSProposed acquisition of Lime Holdings Limited
5th Aug 20167:00 amRNSInterim Report for the period ended 30 June 2016
29th Jun 20167:00 amRNSResults of Annual General Meeting
1st Jun 20169:43 amRNSPosting of Annual Report & Accounts
28th Apr 20167:00 amRNSFinal Results for period ended 31 December 2015
18th Feb 201610:33 amRNSChange of Accounting Reference Date
30th Dec 20157:00 amRNSStatement re possible acquisition
23rd Dec 201512:48 pmRNSSuspension of trading
23rd Dec 201512:45 pmRNSSuspension
18th Dec 201511:07 amRNSAppointment of Financial Advisor
7th Dec 20155:36 pmRNSStatement re: media speculation
27th Nov 20153:00 pmRNSInterim Report for the period ended 31 August 2015
25th Nov 201511:56 amRNSHolding(s) in Company
17th Nov 20153:26 pmRNSHolding(s) in Company
16th Nov 201512:47 pmRNSHolding(s) in Company
16th Nov 20157:00 amRNSAppointment of Broker
11th Nov 20155:15 pmRNSHolding(s) in Company
9th Nov 20157:00 amRNSPlacing of Shares & admission to Official List LSE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.